The Envisia test uses RNA sequencing and machine learning to diagnose idiopathic pulmonary fibrosis.
Sales were driven by a strong flu season and growth in Asia-Pacific business.
The firm also received approval from the Singapore Health Sciences Authority to market the Unyvero blood culture cartridges.
The PCR-based cartridge is designed to detect 21 pneumonia pathogens and 19 genetic markers of antibiotic resistance, and runs on the company's Unyvero system.
IDbyDNA and ARUP Labs will offer their first test for pneumonia through ARUP's established clinical network in the coming weeks.
UK clinicians are to begin a trial using Oxford Nanopore's MinION to diagnose pneumonia, according to the Telegraph.
The tool has been applied to determine the pathogenic cause of hemorrhagic fever, and is powering a new test for respiratory disease pathogens.
The approach is based on a new approval of the BacT/ALERT Virtuo system and new indications for the firm's procalcitonin assay.
For the 40-target panel, the trial found an overall average weighted sensitivity and specificity of 90 and 99 percent, respectively.
In PLOS this week: genetic networks involved in antibiotic sensitivity, syphilis pathogen proteome, and more.
The New York Times and ProPublica look into the close relationship between a startup and Memorial Sloan Kettering Cancer Center.
Yahoo News reports millions of dollars are being transferred from NIH, CDC, and other programs to pay for the housing of detained undocumented immigrant children.
In Science this week: in vitro generation of human reproductive cells, and more.
Researchers gave a handful of octopuses MDMA to find that they too act more social on the drug, Gizmodo reports.